VERA Stock Analysis: Buy, Sell, or Hold?
VERA - Vera Therapeutics, Inc. Class A Common Stock
$40.86
0.36 (0.89%)
▲
5d:
+1.49%
30d:
+3.05%
90d:
-19.31%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 05, 2026
28d
Get Alerted When VERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VERA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VERA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VERA is currently trading at $40.86, which is considered fair relative to its 30-day fair value range of $39.09 to $41.42.
Technical Outlook: Technically, VERA is in a downtrend. Immediate support is located at $37.90, while resistance sits at $42.85.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $79.00 (+93.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VERA is in a downtrend. Immediate support is located at $37.90, while resistance sits at $42.85.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $79.00 (+93.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$39.09 -
$41.42
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 93.3% below Wall St target ($79.00)
Fair Price Analysis
30-Day Fair Range
$39.09 -
$41.42
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$37.90
Resistance Level
$42.86
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.42
Wall Street Target
$79.00
(+93.3%)
Share & Embed Analysis
Last updated: April 05, 2026 11:03 PM ET
Data refreshes hourly during market hours. Next update: 12:03 AM
Data refreshes hourly during market hours. Next update: 12:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
David Lee Johnson
SELL
2579 shares
2026-02-23
Joseph R Young
SELL
3117 shares
2026-02-23
Laurence Matthew Skelton
SELL
1582 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
